John Porter
8PUBLICATIONS
23CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Feb 08, 2024
Mitapivat improves ineffective erythropoiesis and iron overload in adult patients with pyruvate kinase deficiency.Eduard J van Beers, Hanny Al-Samkari, Rachael F Grace
|Oct 02, 2023
Luspatercept stimulates erythropoiesis, increases iron utilization, and redistributes body iron in transfusion-dependent thalassemia.Maciej W Garbowski, Manuel Ugidos, Alberto Risueño
|Jul 27, 2023
SLN124, a GalNAc conjugated 19-mer siRNA targeting tmprss6, reduces plasma iron and increases hepcidin levels of healthy volunteers.John B Porter, Alison Scrimgeour, Alberto Martinez
|Dec 24, 2022
The clinical relevance of detectable plasma iron species in iron overload states and subsequent to intravenous iron-carbohydrate administration.Maciej W Garbowski, Ioav Cabantchik, Chaim Hershko
|Jul 29, 2021
Oral ferroportin inhibitor vamifeport for improving iron homeostasis and erythropoiesis in β-thalassemia: current evidence and future clinical development.John Porter, Ali Taher, Vip Viprakasit
Pageof 2
Frequent Collaborators
4 joint publications
Maciej W Garbowski
2 joint publications
Robert Hider
2 joint publications
Hanny Al-Samkari
2 joint publications
Rachael F Grace
2 joint publications
Andreas Glenthøj
2 joint publications
Wilma Barcellini
2 joint publications
Ali Taher
2 joint publications
Maria Domenica Cappellini
1 joint publications
Frank Richard
1 joint publications
Chaim Hershko
